Previous studies have suggested that the anti-apoptotic genes Bcl-2 and Bcl-xL were markedly upregulated in paclitaxel-resistant hepatoma cell line, and Bcl-xL expression was enhanced by paclitaxel treatment [48]. Here, BCL2L1 is linked to hepatocellular carcinoma.